Compass Therapeutics (CMPX) Times Interest Earned (2018 - 2021)

Compass Therapeutics has reported Times Interest Earned for 9 years, with the latest figure at -$0.63 in Q1 2026.

• Quarterly Times Interest Earned rose 92.53% year-over-year to -$0.63 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.31 (up 91.96% YoY) and the FY2025 annual result came in at -$0.92, up 3.36% from the prior year.
• Times Interest Earned rose to -$0.63 in Q1 2026 per CMPX's latest filing, from -$179.9 in the prior quarter.
• Over five years, Times Interest Earned peaked at -$0.63 in Q1 2026 and troughed at -$179.9 in Q4 2025.
• A 5-year average of -$49.87 and a median of -$22.15 in 2022 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 2700.98% in 2024, then jumped 98.02% in 2025.
• Over 5 years, Times Interest Earned stood at -$42.96 in 2022, then tumbled by 258.31% to -$153.93 in 2023, then jumped by 95.58% to -$6.8 in 2024, then plunged by 2545.8% to -$179.9 in 2025, then jumped by 99.65% to -$0.63 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$0.63, -$179.9, and -$1.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.